ProfileGDS4718 / 231863_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 57% 60% 55% 62% 64% 62% 54% 66% 60% 64% 63% 68% 60% 60% 54% 60% 61% 55% 40% 54% 62% 65% 64% 63% 55% 71% 77% 60% 65% 69% 54% 67% 67% 60% 54% 55% 58% 64% 63% 54% 61% 60% 56% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5027865
GSM549102patient 115, normal, homogenized [OPG study]5.9321657
GSM549104patient 119, normal, homogenized [OPG study]6.1406160
GSM549108patient 138, normal, homogenized [OPG study]5.8350355
GSM549119patient 077, normal, homogenized [OPG study]6.2692662
GSM549133patient 032, cancer, homogenized [OPG study]6.3953264
GSM549139patient 042, cancer, homogenized [OPG study]6.2910462
GSM549099patient 107, normal, homogenized [OPG study]5.7402254
GSM549109patient 139, normal, homogenized [OPG study]6.5379166
GSM549110patient 046, normal, homogenized [OPG study]6.1445460
GSM549114patient 063, normal, homogenized [OPG study]6.3470764
GSM549122patient 082, normal, homogenized [OPG study]6.3324863
GSM549134patient 033, cancer, homogenized [OPG study]6.733568
GSM549136patient 036, cancer, homogenized [OPG study]6.1151860
GSM549140patient 044, cancer, homogenized [OPG study]6.1203660
GSM549111patient 047, normal, homogenized [OPG study]5.7591254
GSM549113patient 057, normal, homogenized [OPG study]6.1089560
GSM549132patient 031, cancer, homogenized [OPG study]6.1584861
GSM549137patient 038, cancer, homogenized [OPG study]5.7821955
GSM549142patient 047, cancer, homogenized [OPG study]5.1260540
GSM549100patient 110, normal, homogenized [OPG study]5.7210854
GSM549107patient 135, normal, homogenized [OPG study]6.2393562
GSM549115patient 068, normal, homogenized [OPG study]6.4759565
GSM549116patient 072, normal, homogenized [OPG study]6.3964564
GSM549120patient 078, normal, homogenized [OPG study]6.3702163
GSM549131patient 030, cancer, homogenized [OPG study]5.7768855
GSM549118patient 074, normal, homogenized [OPG study]7.0041571
GSM549129patient 027, cancer, homogenized [OPG study]7.5713477
GSM549123patient 088, normal, homogenized [OPG study]6.1433560
GSM549124patient 006, cancer, homogenized [OPG study]6.4617965
GSM549126patient 015, cancer, homogenized [OPG study]6.7919269
GSM549128patient 025, cancer, homogenized [OPG study]5.7219154
GSM549103patient 117, normal, homogenized [OPG study]6.6105867
GSM549117patient 073, normal, homogenized [OPG study]6.5900667
GSM549138patient 041, cancer, homogenized [OPG study]6.1562660
GSM549141patient 045, cancer, homogenized [OPG study]5.737854
GSM549130patient 028, cancer, homogenized [OPG study]5.809255
GSM549101patient 111, normal, homogenized [OPG study]6.031558
GSM549105patient 128, normal, homogenized [OPG study]6.3801564
GSM549106patient 134, normal, homogenized [OPG study]6.3627863
GSM549112patient 048, normal, homogenized [OPG study]5.7278454
GSM549125patient 011, cancer, homogenized [OPG study]6.1915861
GSM549127patient 024, cancer, homogenized [OPG study]6.202560
GSM549135patient 035, cancer, homogenized [OPG study]5.8778256